Resonance recently completed the installation of dehumidifier to control RH in its finishing areas to enable the company to manufacture certain hygroscopic APIs.
Dr. Ramachandra Puranik joined Resonance as General Manager. He comes with 20+ years experience in generic product development as well as NCE development, most recently with Astra Zeneca.
Long-term stability study for Naloxone Hydrochloride was completed and data analyzed.
Resonance secured the WC for Oxybutynin Hydrochloride after a site and document.